PPA
STML

Parametric Portfolio Associates’s Stemline Therapeutics, Inc. STML Stock Holding History

Parametric Portfolio Associates’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,612
Closed -$51K – 4058
2020
Q1 		$51K Sell
10,612
-1,716
-14% -$11.1K ﹤0.01% 3835
2019
Q4 		$131K Sell
12,328
-243
-2% -$2.41K ﹤0.01% 3819
2019
Q3 		$131K Buy
+12,571
New +$164K ﹤0.01% 3792
2018
Q3 		– Sell
-10,803
Closed -$173K – 3993
2018
Q2 		$173K Buy
10,803
+280
+3% +$5K ﹤0.01% 3723
2018
Q1 		$161K Sell
10,523
-323
-3% -$5.04K ﹤0.01% 3805
2017
Q4 		$169K Buy
+10,846
New +$145K ﹤0.01% 3778
2015
Q2 		– Sell
-16,457
Closed -$238K – 4023
2015
Q1 		$238K Buy
16,457
+307
+2% +$4.7K ﹤0.01% 3677
2014
Q4 		$276K Buy
+16,150
New +$233K ﹤0.01% 3623

Parametric Portfolio Associates's STML Position: Q2 2020 in Review

Parametric Portfolio Associates sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 10,612 shares — an estimated $51K sold.

Parametric Portfolio Associates first reported a position in STML in Q4 2014 and held it in 8 quarters. The position peaked at $276K in Q4 2014. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

  • Parametric Portfolio Associates reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Parametric Portfolio Associates sold 10,612 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $51K.
  • Parametric Portfolio Associates first reported a position in Stemline Therapeutics, Inc. in Q4 2014 and held it in 8 quarters.
  • Parametric Portfolio Associates's Stemline Therapeutics, Inc. position peaked at $276K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Parametric Portfolio Associates's 13F filing for Q2 2020, filed 13 Aug 2020.